The largest database of trusted experimental protocols

181 protocols using dual luciferase reporter gene assay kit

1

SOX9 Regulation of LCN2 Promoter

Check if the same lab product or an alternative is used in the 5 most similar protocols
Based on the study [14 (link)], a full-length human SOX9 cDNA was synthesized according to the UCSC (http://genome.ucsc.edu) sequence and cloned into pcDNA3.1(+) vector (Promega, Madison, WI, USA) to generate pcDNA3.1-h_SOX9. The binding motif of the transcription factor SOX9 on the promoter region of human LCN2 was predicted on the website (http://cisbp.ccbr.utoronto.ca/index.php). The human LCN2 promoter region was constructed into pGL3-Basic vector (E1751, Promega) to obtain a human LCN2-wild-type (WT) recombinant vector, and the binding motif of SOX9 on LCN2 was mutated and constructed into pGL3-Basic vector (Promega) to produce a recombinant vector of human LCN2 mutant (MUT). The constructed luciferase reporter plasmids WT and MUT were cotransfected with pcDNA3.1 (empty) or pcDNA3.1-h_SOX9 into HEK-293T cells. The luciferase activity was checked using Dual Luciferase Reporter Gene Assay Kit (E1910, Promega) and SpectraMaxi3 reader multifunctional microplate reader (Molecular Devices, San Jose, CA, USA) with Renilla luciferase as the internal control.
+ Open protocol
+ Expand
2

Dual-Luciferase Assay for circMTND5/UCP2 Binding Site Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The wide-type binding sites of circMTND5/UCP2 were inserted into the pmirGLO Dual-Luciferase miRNA Target Expression Vector (Promega, CA, USA). The mutated binding site sequences of circMTND5/UCP2 were generated by CloudSeq Biotech (Shanghai, China). Wild-type or mutated circMTND5/UCP2 was cotransfected with MIR6812 mimic/negative control into HEK293T cells. After transfection for 48 h, cells were harvested and the luciferase activity was measured using the Dual-Luciferase Reporter Gene Assay Kit in a luciferase reporter system (Promega, CA, USA).
+ Open protocol
+ Expand
3

EBV-miR-BHRF1-1 Binding to p53 Validation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Renilla-luciferase assay was performed to verify whether EBV-miR-BHRF1-1 is combined with p53 gene. The pmirGLO Dual-Luciferase miRNA Target Expression Vector is designed to quantitatively evaluate miRNA activity by the insertion of miRNA target sites 3´-UTR region of the firefly luciferase gene (luc2). EBV-miR-BRHF1-1 or negative controls (NC) were transfected together with pmirGLO vector in the 293T cell line by using lipofectamine 2000 (Invitrogen, Carlsbad, CA). The ratios of Renilla versus firefly signals was used to measure the efficiency of transfection by using dualluciferase reporter gene assay kit (Promega, Madison, WI) at 24 hours and 48 hours after transfection.
+ Open protocol
+ Expand
4

Dual-Luciferase Assay for m6A Sites

Check if the same lab product or an alternative is used in the 5 most similar protocols
The dual-luciferase vector pmirGLO was purchased from Promega (Promega, cat. C838A). The 3ʹ UTR of PDGFC was amplified by PCR using genomic DNA from 293 T cells as a template. A clone with a sequence that was identical to the NCBI reference sequence NM_016205 was cloned into the pmirGLO vector at the SacI and SalI restriction sites. Two putative m6A recognition sites were identified in the 3ʹ UTR. Mutagenesis from A to T was generated using the QuikChange II Site-Directed Mutagenesis Kit (Agilent, USA) according to the manufacturer’s instructions. Luciferase activity was measured with a Dual-Luciferase Reporter Gene Assay Kit (Promega, cat. E1910). The activity of firefly luciferase was normalized to that of Renilla luciferase to evaluate reporter expression efficiency.
+ Open protocol
+ Expand
5

Computational Prediction and Validation of miRNA-Bcl-2 Interactions

Check if the same lab product or an alternative is used in the 5 most similar protocols
MiRNAs targets were predicted using the algorithms TargetSan (https://www.targetscan.org). The Bcl-2 gene was input and then a list of miRNAs that target certain base pairs on Bcl-2 were shown in the map. The levels of these miRNAs in our experimental conditions were then examined. Only those that had a significant change by UUO with/without IGF-1 were used as candidates for further analyses. Luciferase-reporters were constructed using molecular cloning technology. Target sequences for Bcl-2 3′-UTR and Bcl-2 3′-UTR with a site mutation at miR-429 binding site (Bcl-2 3′-UTR mut) were purchased from Creative Biogene (Shirley, NY, USA). Purified renal epithelial cells were seeded in 24-well plates for 24 hours, after which they were co-transfected with 1 μg of Luciferase-reporter plasmids and miR-429-modified plasmids. Luciferase activities were evaluated using the dual-luciferase reporter gene assay kit (Promega, Beijing, China).
+ Open protocol
+ Expand
6

Validation of miR-497 targeting CDC42

Check if the same lab product or an alternative is used in the 5 most similar protocols
The potential target site of miR-497 on 3′ UTR of CDC42 was predicted using miRDB database (http://mirdb.org/). DNA fragments containing a CDC42 WT sequence and CDC42 mutant (MT) sequence were inserted into the pmirGLO basic vector (Promega, Madison, WI, USA), respectively. Then, 293T cells were co-transfected with reporter vectors and miR-negative control (NC) or miR-497 mimics. After 48 h, luciferase activities of the cells were measured using the Dual Luciferase Reporter Gene Assay Kit (Promega, Madison, WI, USA). The luciferase activity of firefly was normalized to that of Renilla.
+ Open protocol
+ Expand
7

Validating the Regulatory Relationship between circ_0000790, miR-374c, and FOXC1

Check if the same lab product or an alternative is used in the 5 most similar protocols
The relationship between circ_0000790 and miR-374c, miR-374c, and FOXC1 was analyzed using a biological prediction website (https://cm.jefferson.edu/rna22/Interactive/), and the dual-luciferase reporter gene assay was employed to further verify whether circ_0000790 or FOXC1 was the target gene of miR-374c. According to the predicted binding site, the artificially synthesized mRNA 3′ UTR fragments of circ_0000790 and FOXC1 were inserted into plasmid pGL3-basic (P2129, Shanghai Hewu Biotechnology, Shanghai, China). The complementary sequence mutation site of the seed sequence was designed on FOXC1-wild-type and constructed into the reporter plasmids, which were comprised of a combination of Luc-circ_0000790-wild-type, Luc-circ_0000790-mut, FOXC1-wild-type, and FOXC1-mut, respectively. The correctly sequenced luciferase reporter plasmids were co-transfected into HEK293T cells with miR-374c and NC, respectively. The luciferase activity was measured using the dual-luciferase reporter gene assay kit (E1910, Promega, Madison, WI, USA). Fluorescence intensity was measured using a GloMax 20/20 luminometer fluorescence detector (E5311, Shaanxi Zhongmei Biotechnology, Shanxi, China). The experiment was repeated three times independently.
+ Open protocol
+ Expand
8

Dual-Luciferase Assay for Transfection Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
After transfection 24 h, according to the manufacturer’s instructions, luciferase reporter analyses were performed using a dual-luciferase reporter gene assay kit (Promega, Madison, WI, USA), and Firefly and Renilla luciferase activity were measured. The 293T cells were removed from growth media and lightly washed in 1× PBS. After the culture plate added 100 μL Passive Lysis Buffer (PLB) and then shaken at room temperature for 15 min, the solution was transferred to the PCR tube, centrifuged by 12,000 rpm for 5 min, and collected the supernatant. Add the collected supernatant at 5 μL per hole in the enzyme plate, then add 50 μL luciferase assay reagent II (LARII) to each well, gently shake and mix, and detect the fluorescence value of Firefly luciferase. Then 50 μL of Stop&Glo, was added to each well to detect the fluorescence value of Renilla luciferase. The relative Firefly luciferase activity was calculated by normalizing to Renilla luciferase activity. All experiments were performed in three independent biological replications, and reactions of each sample were carried out in triplicate. All data were expressed as means ± the SEM and determined by one-way ANOVA. p values < 0.05 were considered statistically significant.
+ Open protocol
+ Expand
9

Evaluating tRF-Leu-AAG miRNA Regulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Wild-type and mutant UPF1 were constructed and then co-transfected with tRF-Leu-AAG mimic/negative control and wild-type/mutant UPF1 into cells. Dual-Luciferase Reporter gene assay kit (Promega, Madison, WI, USA) was used to detect the activity of cell luciferase.
+ Open protocol
+ Expand
10

Validating miR-873 Regulation of ABCA1

Check if the same lab product or an alternative is used in the 5 most similar protocols
Online databases (http://www.microrna.org/; http://mirdb.org/index.html) were used to predict the putative binding site of miR-873 in 3′-UTR of ABCA1. U251 cells were transiently cotransfected with a luciferase reporter plasmid encoding the 3′-untranslated region (3′-UTR) of ABCA1 (pMIR-Report-ABCA1) and the pcDNA-3.1(-)-miR-873 vector or an empty vector. A dual-luciferase reporter assay system was used to detect the functional regulation of ABCA1 mRNA by miR-873. The luciferase activity was quantified 36 h after transfection using the Dual- Luciferase Reporter Gene Assay Kit (Promega, Madison, WI, USA) and a luminometer system (Tecan Spark™ 10M, Tecan, Switzerland). The firefly luciferase activity was normalized with the Renilla luciferase activity to control for the transfection efficiency.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!